NCT00305396View on ClinicalTrials.gov

Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

March 31, 2005

Conditions
Kidney Transplantation
Interventions
DRUG

Sirolimus

Trial Locations (1)

37232

Vanderbilt University Medical Center/Nashville VA, Nashville

All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

Vanderbilt University

OTHER

NCT00305396 - Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation | Biotech Hunter | Biotech Hunter